|
EMLA
EMLA is a mild topical pain reliever consisting of dilute (2.5%) mixture of lidocaine and prilocaine in equal parts. Outside of electrolysis use, it has limited use for procedures due to its minimal pain relieving properties. While EMLA is regularly used in electrolysis, patients will likely find very limited pain relief. The concept behind the mixing of lidocaine and prilocaine is seen in its name. The brand name, EMLA, was chosen as it is an acronym for Eutectic Mixture of Local Anesthetics. Eutectic refers the a mixture whose melting point is lower than that of its constituent parts. The goal of such a topical anesthetic is to maintain the eutectic temperature as to allow for greater absorption through the skin barrier. However, EMLA is contained in a cream base, detracting from its eutectic potential by requiring thick application and covering for a long duration. For the greatest effect when using EMLA or other topical preparations, the skin must be thoroughly cleansed/degreased. This process is called de-fatting. In the case of EMLA cream, an occlusive (film covering) dressing must be applied over the drug. For greater detail in this type of application, please see Occlusive Dressings.
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Site
Help This Site may also be accessed via www.tgcare.com Transgender
Care Health Information Archive
|